Return to site

Khiron Life Sciences Makes Strategic Moves In Southmerica

.rssg-digest display: flex; flex-wrap: nowrap; margin-bottom: 40px; .rssg-col-left flex: 0 0 250px; margin-bottom: 10px; .rssg-col-right flex-grow: 1; overflow: hidden; .rssg-img border: 1px solid #dadada; border-radius: 5px; height: 130px; object-fit: cover; width: 220px; .rssg-title font-size: large; font-weight: 700; line-height: 1.2; margin-bottom: 5px; .rssg-source-date font-size: x-small; margin-bottom: 3px; .rssg-desc font-size: small; @media (max-width: 768px) .rssg-digest flex-wrap: wrap; margin: 0 10px 60px 10px; .rssg-col-left flex-basis: 100%; height: 0; margin-bottom: 20px; overflow: hidden; padding-top: 56.25%; position: relative; .rssg-img height: 100%; left: 0; position: absolute; top: 0; width: 100%;
Cannabis Industry Journal • December 11, 2019, 7:34 pm
Khiron Life Sciences Corp. has played an interesting game globally for some time now. Far from a “high flier” in the first tiers of Canadian cannabis companies to watch, that may be changing. Not to…
Marijuana – Grizzle • December 11, 2019, 8:42 pm
Could a claim of fraudulent conveyance delay or derail the merger of Tilray and private equity owner Privateer Holdings?
Marijuana: news, laws, advocacy, and discussion. • December 12, 2019, 2:13 am
I haven’t smoked pot in 25 years and back then there were always urban legends about how long it stays in your system for a drug test. Either saliva or urine. What’s the science on this nowadays? How…
High & Marijuana Blog | Cannabis • December 11, 2019, 6:00 am
The latest study out of Brazil found that twice-daily use of cannabis-based CBD has resulted in significant improvements among adolescents with autism-spectrum disorder. The study, whose results were…

All Posts

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly